Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 42445

1.

Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.

Shoji S, Hiraiwa S, Ogawa T, Kawakami M, Nakano M, Hashida K, Sato Y, Hasebe T, Uchida T, Tajiri T.

Int J Urol. 2017 Feb 21. doi: 10.1111/iju.13306. [Epub ahead of print]

PMID:
28222486
2.

Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.

Lehto US, Tenhola H, Taari K, Aromaa A.

Br J Cancer. 2017 Feb 21. doi: 10.1038/bjc.2017.30. [Epub ahead of print]

PMID:
28222069
3.

Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System.

Salloum RG, O'Keeffe-Rosetti M, Ritzwoller DP, Hornbrook MC, Lafata JE, Nielsen ME.

J Oncol Pract. 2017 Feb 21:JOP2016018333. doi: 10.1200/JOP.2016.018333. [Epub ahead of print]

PMID:
28221895
4.

Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.

Eapen RS, Herlemann A, Washington SL 3rd, Cooperberg MR.

Curr Opin Urol. 2017 Feb 17. doi: 10.1097/MOU.0000000000000383. [Epub ahead of print]

PMID:
28221220
5.

Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017.

Carlsson SV, Roobol MJ.

Curr Opin Urol. 2017 Feb 17. doi: 10.1097/MOU.0000000000000382. [Epub ahead of print]

PMID:
28221219
6.

The provision of dietary and physical activity advice for men diagnosed with prostate cancer: a qualitative study of the experiences and views of health care professionals, patients and partners.

Sutton E, Hackshaw-McGeagh LE, Aning J, Bahl A, Koupparis A, Persad R, Martin RM, Lane JA.

Cancer Causes Control. 2017 Feb 20. doi: 10.1007/s10552-017-0861-7. [Epub ahead of print]

PMID:
28220328
7.

Radiolabelled PSMA small molecule inhibitors.

Will L, Sonni I, Kopka K, Kratochwil C, Giesel FL, Haberkorn U.

Q J Nucl Med Mol Imaging. 2017 Feb 17. doi: 10.23736/S1824-4785.17.02977-6. [Epub ahead of print]

PMID:
28217987
8.

Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies.

Sanchez E, Pastuszak AW, Khera M.

Transl Androl Urol. 2017 Feb;6(1):28-36. doi: 10.21037/tau.2016.10.01. Review.

PMID:
28217448
9.

An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology.

King RB, McMahon SJ, Hyland WB, Jain S, Butterworth KT, Prise KM, Hounsell AR, McGarry CK.

Cancer Nanotechnol. 2017;8(1):3. doi: 10.1186/s12645-017-0027-z. Review.

PMID:
28217177
10.

Skeletal Metastases Presenting as Superscan on Technetium 99m Methylene Diphosphonate Whole Body Bone Scintigraphy in Different Type of Cancers: A 5-Year Retro-prospective Study.

Manohar PR, Rather TA, Khan SH, Malik D.

World J Nucl Med. 2017 Jan-Mar;16(1):39-44. doi: 10.4103/1450-1147.181153.

PMID:
28217018
11.

<i>Trichosanthes kirilowii</i> Exerts Androgenic Activity via Regulation of PSA and KLK2 in 22Rv1 Prostate Cancer Cells.

Jeong SJ, Choi JY, Dong MS, Seo CS, Shin HK.

Pharmacogn Mag. 2017 Jan-Mar;13(49):153-158. doi: 10.4103/0973-1296.197657.

PMID:
28216900
12.

Outcomes of prostate cancer screening by 5-alpha reductase inhibitor usage.

Murtola TJ, Virkku A, Talala K, Stenman UH, Taari K, Tammela TL, Auvinen A.

J Urol. 2017 Feb 16. pii: S0022-5347(17)30290-2. doi: 10.1016/j.juro.2017.02.069. [Epub ahead of print]

PMID:
28216328
13.

TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer.

Adra N, Cheng L, Hanna NH, Durm G.

Clin Genitourin Cancer. 2017 Feb 1. pii: S1558-7673(17)30036-8. doi: 10.1016/j.clgc.2017.01.020. [Epub ahead of print] No abstract available.

PMID:
28216280
15.

Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project.

Ukawa S, Nakamura K, Okada E, Hirata M, Nagai A, Yamagata Z, Muto K, Matsuda K, Ninomiya T, Kiyohara Y, Kamatani Y, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group., Tamakoshi A.

J Epidemiol. 2017 Feb 17. pii: S0917-5040(16)30105-8. doi: 10.1016/j.je.2016.12.008. [Epub ahead of print]

PMID:
28215481
16.

Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.

Egevad L, Samaratunga H, Delahunt B.

Int J Urol. 2017 Feb 17. doi: 10.1111/iju.13305. [Epub ahead of print] No abstract available.

PMID:
28213918
17.

The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.

Moukayed M, Grant WB.

Rev Endocr Metab Disord. 2017 Feb 17. doi: 10.1007/s11154-017-9415-2. [Epub ahead of print] Review.

PMID:
28213657
18.

Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis.

Ali A, Hoyle A, Baena E, Clarke NW.

Curr Opin Urol. 2017 Feb 16. doi: 10.1097/MOU.0000000000000385. [Epub ahead of print]

PMID:
28212121
19.

The role of biomarkers in undiagnosed men.

Dani H, Loeb S.

Curr Opin Urol. 2017 Feb 16. doi: 10.1097/MOU.0000000000000384. [Epub ahead of print]

PMID:
28212119
20.

Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.

Li J, Hall IJ, Zhao G.

Cancer Causes Control. 2017 Feb 16. doi: 10.1007/s10552-017-0860-8. [Epub ahead of print]

PMID:
28210882
Items per page

Supplemental Content

Loading ...
Support Center